Metformin: Should it be the first therapeutic option in the patient with high-risk diabetes?
pp. 58-64
DOI:
https://doi.org/10.7775/rac.es.v89.i1.19784Abstract
Downloads
Published
2025-04-15
Issue
Section
CONTROVERSIAS
License
Copyright (c) 2025 Argentine Journal of Cardiology

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.







